🇵🇱 INSTYTUT EKSPERTYZ SĄDOWYCH im. Prof. dra Jana Sehna PL
Materials & polymersAutomotive
INSTYTUT EKSPERTYZ SĄDOWYCH im. Prof. dra Jana Sehna is a laboratory accredited by PCA under number AB 1567 (Kraków, Poland). Its accreditation scope covers 15 test methods in the following areas: Materials & polymers, Automotive. Test objects include: Blood, Material of human origin, Blood and urine from living persons Blood, urine, vitreous humour a…, Blood and urine from living persons. Blood, urine, vitreous humour….
At a glance
- Accreditation number: PCA AB 1567
- Methods in scope: 15
- Types of test objects: 12
- City: Kraków, Poland
- Accreditation number
- AB 1567
- Accreditation body
- PCA
- Address
- ul. Westerplatte 9, 31 – 033 Kraków
- City
- Kraków, Poland
What this laboratory tests (12)
- Blood — 3 methods
- Material of human origin — 2 methods
- Blood and urine from living persons Blood, urine, vitreous humour and drip fluids from internal organs from corpses — 1 method
- Blood and urine from living persons. Blood, urine, vitreous humour from corpses — 1 method
- Documents — 1 method
- Fragments of paint coating — 1 method
- Fragments of single fibres, textiles — 1 method
- Handwriting — 1 method
- Impression of footwear soles, shoes Impression of tyres, tyres — 1 method
- Impressions of finger and palm papillary lines — 1 method
- Substrates – carriers of papillary line traces — 1 method
- Urine — 1 method
Accreditation scope — test methods (15)
| No. | Test object | Methodology / Parameters | Technique | Reference document | |
|---|---|---|---|---|---|
| Test methods | |||||
| 1 | Material of human origin | Identification of the type of biological trace. Specific features of biological material. Method: Immunochromatographic and biochemical. Individualisation of biological traces. DNA analysis of polymorphic STR systems. Method: Multiplex PCR with capillary electrophoresis. Kinship analysis. DNA polymorphism analysis using STR systems. Method: Multiplex PCR with capillary electrophoresis. | PB.G.011) | ||
| 2 | Material of human origin | Individualisation of biological traces. Analysis of mitochondrial DNA (mtDNA) polymorphism. DNA sequencing method. | PB.G.021) | ||
| 3 | Blood and urine from living persons Blood, urine, vitreous humour and drip fluids from internal organs from corpses | Ethyl alcohol concentration. Range: (0,10 – 16,0) ‰ Headspace gas chromatography with flame ionisation detection (HS-GC-FID) and spectrophotometric method (enzymatic ADH). | PB.TA.01 wydanie 7 z dnia 27.11.2024 | ||
| 4 | Blood and urine from living persons. Blood, urine, vitreous humour from corpses | Ethyl alcohol concentration. Range: (0,10-20,0) ‰. Headspace gas chromatography with flame ionisation detection (HS-GC-FID) on two columns of different polarity | PB.TA.02 wydanie 1 z dnia 27.11.2024 | ||
| 5 | Blood | Cannabinoid concentration Range: THC, CBD (1,0 - 20) ng/ml 11OH-THC (1,0 - 15) ng/ml THCCOOH, 7COOH-CBD (5 - 100) ng/ml HHC, HHCP, HHC acetate (1,0 - 20) ng/ml 11-OH-HHC (1,0 - 15) ng/ml HHCCOOH (5 - 100) ng/ml Amphetamine, methamphetamine, MDMA concentration Range: amphetamine (15 - 800) ng/ml methamphetamine, MDMA (15 - 400) ng/ml Cocaine and its metabolites concentration Range: cocaine (10 - 160) ng/ml benzoylecgonine, ecgonine methyl ester (50 - 800) ng/ml Opioid concentration Range: morphine, hydrocodone, naloxone, desomorphine, dextromethorphan (10 - 160) ng/ml codeine, EDDP, dextrorphan, oxycodone (10 - 320) ng/ml dihydrocodeine (20 - 160) ng/ml methadone (20 - 320) ng/ml, pethidine (50 - 3200) ng/ml tramadol (100 - 3200) ng/ml High-performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) | PB.TT.04 wydanie 2 z dnia 6.02.2025 | ||
| 6 | Blood | Presence of amphetamine, methamphetamine, cannabinoid, benzodiazepine, opioid, cocaine and benzoylecgonine derivatives Amphetamine derivatives expressed as amphetamine ≥ 25 ng/ml Methamphetamine derivatives expressed as MDMA ≥ 25 ng/ml Cannabinoids expressed as THCCOOH ≥ 5 ng/ml Benzodiazepine derivatives expressed as clonazepam ≥ 10 ng/ml Cocaine and benzoylecgonine expressed as benzoylecgonine ≥ 50 ng/ml Opioids expressed as morphine ≥ 10 ng/ml ELISA method | PB.TT.01 wydanie 2 z dnia 15.12.2023 | ||
| 7 | Urine | Presence of amphetamine, methamphetamine, cannabinoid, benzodiazepine derivatives, opioids, cocaine and benzoylecgonine Amphetamine derivatives expressed as amphetamine ≥ 500 ng/ml Methamphetamine derivatives expressed as MDMA ≥ 500 ng/ml Cannabinoids expressed as THCCOOH ≥ 50 ng/ml Benzodiazepine derivatives expressed as oxazepam ≥ 300 ng/ml Cocaine and benzoylecgonine expressed as benzoylecgonine ≥ 300 ng/ml Opioids expressed as morphine ≥ 300 ng/ml ELISA method | PB.TT.01 wydanie 2 z dnia 15.12.2023 | ||
| 8 | Blood | Presence of amphetamine, methamphetamine, cannabinoid, benzodiazepine and imidazopyridine, opioid, cocaine derivatives and cathinone derivatives Amphetamine derivatives Range: selegiline > 20 ng/ml amphetamine, methylphenidate, ephedrine > 25 ng/ml Methamphetamine derivatives Range: methamphetamine, MDMA, MDA, MDEA > 25 ng/ml Cannabinoids Range; THCCOOH, HHCCOOH > 5 ng/ml Benzodiazepine and imidazopyridine derivatives Range: flunitrazepam > 1 ng/ml alprazolam > 2 ng/ml clonazepam > 10 ng/ml diazepam, nordiazepam > 20 ng/ml midazolam > 30 ng/ml bromazepam > 50 ng/ml zolpidem > 80 ng/ml Cocaine derivatives (cocaine > 10 ng/ml; benzoylecgonine, ecgonine methyl ester >50 ng/ml) Opioids Range: fentanyl > 0,5 ng/ml buprenorphine > 1 ng/ml 6-MAM, dextromethorphan > 5 ng/ml codeine, methadone, morphine > 10 ng/ml thebaine > 20 ng/ml tramadol, EDDP > 50 ng/ml pethidine > 100 ng/ml Cathinone derivatives Range: mephedrone, 4-CMC > 5 ng/ml Method: high performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) | PB.TT.02 wydanie 1 z dnia 29.07.2024 | ||
| 9 | Impressions of finger and palm papillary lines | Identification of fingerprint impressions. | PB.KD.01 wydanie 12 z dnia 26.02.2025 | ||
| 10 | Substrates – carriers of papillary line traces | Visualization of fingermarks Techniques: - Visual examination, - DFO, - Ninhydrin, - 1,2 - IND, - Cyanoacrylate polymerization, - Basic Yellow 40, - Fingerprint powders of the type: ferromagnetic, light, special - Wet Powder, - Amido Black, - Acid Yellow 7, - Acid Violet 17, - Ardrox, - Hungarian Red, - DMAC, - Sudan Black. | PB.KD.02 wydanie 3 z dnia 25.04.2025 | ||
| 11 | Handwriting | Identification testing of handwriting. Graphic-comparative method. | PB.KP.01 wydanie 5 z dnia 07.01.2020 | ||
| 12 | Documents | Examination of alterations in documents. Optical methods (stereoscopic microscopy, near-infrared absorption analysis, luminescence analysis). | PB.KP.02 wydanie 5 z dnia 07.01.2020 | ||
| 13 | Impression of footwear soles, shoes Impression of tyres, tyres | Class, individualising and individual features of footwear. Class, individualising and individual features of tyres. Toolmark examinations. | PB.KM.01 wydanie 5 z dnia 08.12.2022 | ||
| 14 | Fragments of single fibres, textiles | Structural features of fibres and their colour. Identification and comparison examination of fibres. Optical microscopy and microspectrophotometry methods. | PB.KM.02 wydanie 4 z dnia 07.05.2021 | ||
| 15 | Fragments of paint coating | Identification and comparative testing. Identification of the polymer binder, fillers, pigments, colour, structure. Infrared IR spectrometry method. | PB.KM.03 wydanie 3 z dnia 07.01.2020 | ||
Reference standards (14)
PB.G.011)
PB.G.021)
PB.KD.01 wydanie 12 z dnia 26.02.2025
PB.KD.02 wydanie 3 z dnia 25.04.2025
PB.KM.01 wydanie 5 z dnia 08.12.2022
PB.KM.02 wydanie 4 z dnia 07.05.2021
PB.KM.03 wydanie 3 z dnia 07.01.2020
PB.KP.01 wydanie 5 z dnia 07.01.2020
PB.KP.02 wydanie 5 z dnia 07.01.2020
PB.TA.01 wydanie 7 z dnia 27.11.2024
PB.TA.02 wydanie 1 z dnia 27.11.2024
PB.TT.01 wydanie 2 z dnia 15.12.2023
PB.TT.02 wydanie 1 z dnia 29.07.2024
PB.TT.04 wydanie 2 z dnia 6.02.2025